Event date: January 15, 2025
Topic: Let’s Learn More About Multiple Sclerosis and Disease progression.
What is PIRA? How do I learn more of the efficacious treatment options for Multiple Sclerosis?
Shared Decision Making: How do I choose which medication is best for me?
Presented by: Scott L. Gold, MD
This educational program was supported by TG Therapeutics and Sanofi.
Sign up for the Monthly " MS Beacon" Newsletter here:
https://msviewsandnews.org/join-the-community/
This educational program, designed for the Multiple Sclerosis community video was provided by: MS Views and News, a 501c3 Not-for-Profit organization.
See our Archived articles here: https://msviewsandnews.org/blog
Join us on Facebook: https://www.facebook.com/msviewsandnews
Visit us on X (formerly Twitter): https://www.twitter.com/MSViewsandNews
Visit us on Instagram: https://www.instagram.com/msviewsandnews
Your support is needed to help us maintain this channel. Every dollar counts. ..
To donate, please click: https://msviewsandnews.org/donate . - Thank you
Donating to MS Views and News is a meaningful and impactful way to make a positive difference in the lives of those affected by Multiple Sclerosis (MS). The MS Views and News organization is dedicated to providing needed educational information, and resources to individuals living with MS, as well as their caregivers and loved ones.
Your donation will enable the association to organize informative in-person educational events and virtual webinars ensuring that those affected by MS have access to the latest information on treatments and management.
In addition, your generosity helps raise awareness about MS and fosters a sense of community, reducing the isolation often experienced by those living with this multiple sclerosis. By donating, you become a crucial part of the fight against MS, offering hope, empowerment, and a brighter future to countless individuals and families impacted by this challenging disease.
Please Donate Now = https://msviewsandnews.org/donate
***************************************